SARS-CoV-2 spike-protein targeted serology test results and their association with subsequent COVID-19-related outcomes

SARS-CoV-2 spike-protein targeted serology test results and their association with subsequent COVID-19-related outcomes

ImportanceIn the absence of evidence of clinical utility, the United States' Centers for Disease Control and Prevention does not currently recommend the assessment of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) spike-protein antibody levels. Clinicians and their patients, espec...

Full description

Bibliographic Details
Main Authors: Harvey W. Kaufman, Stanley Letovsky, William A. Meyer, Laura Gillim, Magdalene M. Assimon, Carly A. Kabelac, John W. Kroner, Shannon L. Reynolds, Marcia Eisenberg
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-07-01
Series:Frontiers in Public Health
Subjects:
SARS-CoV-2 spike antibody
SARS-CoV-2
COVID-19
immunocompromised conditions
immune protection
Online Access:https://www.frontiersin.org/articles/10.3389/fpubh.2023.1193246/full

Internet

https://www.frontiersin.org/articles/10.3389/fpubh.2023.1193246/full

Similar Items